Roche Deal Drives DeCode s Q3 Revenues Up 57% | GenomeWeb

NEW YORK, Nov 14 – DeCode Genetics’ third quarter revenues surged 57.1 percent, pushed higher by revenues stemming from its collaboration with Roche, the population-genomics company reported Tuesday.

Revenue for the quarter totaled $5.6 million, compared with $3.5 million for the year ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.